Alexander Volkanovski is set to welcome his fourth child to the world later in 2025 -- and the UFC champ swears it's his last little one -- soooooooo, vasectomy?! The 36-year-old, who recently ...

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in ...

Attention deficit hyperactivity disorder (ADHD) and hypersexuality are linked but it's still unclear how ADHD affects sexual behavior. ADHD is characterized by restlessness, impulsivity, and ...

We are proud to continue Baxter's legacy of innovation in sealing and hemostasis." Hemopatch Sealing Hemostat is a ready-to-use absorbable collagen pad intended for tissue sealing, dura sealing ...

Hemostats are medical devices used to control bleeding during surgeries, providing an essential function in both minor and major procedures. The global hemostats market is witnessing rapid expansion ...

A vasectomy is a form of birth control, and a relatively minor outpatient procedure. It’s usually done under local anesthesia, and has a short healing time. The penis and genital area may feel a ...

Hemopatch Sealing Hemostat with room temperature storage now available in Europe New product evolution enables direct accessibility in the operating room Innovation is a direct result of collaborative ...

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium ...

WASHINGTON — House Armed Services Committee Chairman Mike Rogers (R-Ala.) urged Pentagon officials on Tuesday not to proceed with rumored cuts to US forces in Europe as Russia’s war on Ukraine ...

Harley-Davidson’s Jochen Zeitz plans to retire as CEO in 2025, the company said Tuesday, ending a five-year tenure marked by efforts to revive the American motorcycle maker struggling with ...

However, the initial enthusiasm waned as clinical studies failed to show clear clinical benefits of hemostatic treatments when patients were selected based on the presence of this imaging marker. In ...

The hemostat market is projected to experience robust growth over the next decade, with the market expected to grow from a valuation of USD 78.70 million in 2022 to reach an estimated USD 134.43 ...